ScripAlready riding high with positive early data for its long-acting GLP-1 analog candidate MET-0971, Metsera grabbed attention again on June 9 with Phase I data for its amylin analog MET-233i, which prod
ScripThe pharmaceutical industry in Europe has criticized the Council of the EU’s adoption of a package of legislative reforms for medicines, claiming that the continent’s innovation-unfriendly environment
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D
ScripJazz and Roche can both expect a sales boost after a combination of their drugs has improved overall survival in extensive-stage small-cell lung cancer (SCLC). Full data from the Phase III IMforte tri